Skip to content
    Sectoral Asset Management logo

    Sectoral Asset Management

    Montreal, CanadaFounded 2000
    www.sectoral.comLinkedIn
    HealthcareBiotech & Life Sciences

    Sectoral Asset Management is an SEC-registered investment advisor exclusively focused on the global healthcare sector, managing both public equity and late-stage venture capital strategies. Founded in 2000 and headquartered in Montreal, the firm's NEMO family of funds invests in innovative biotech and medtech companies at the clinical stage.

    Deal activity decreased year-over-year (3 deals in the last 12 months vs 5 prior). Average disclosed round size is $61.4M (across 51 rounds with reported amounts).

    Find people at Sectoral Asset Management on Goldilocks AI

    Portfolio

    46

    Fund Size

    $150M

    Top Stage

    Series B

    Last 12 Mo

    3

    Team

    FB

    FRANÇOIS BEAUBIEN, Ph.D., CFA

    Partner

    AB

    ANTOINE BLONDIN

    Regional Director – Europe

    AA

    AREK ALSZKO

    Director of Information Technology

    BG

    Brett Goodin

    Director Australia

    HR

    HOWARD RIBACK

    Director, Venture Capital

    YZ

    YINGDONG ZHANG

    Regional Director - Asia

    GS

    GAUTHIER SANZ

    Senior Analyst

    JM

    JONATHAN MA

    Operations Analyst

    TM

    TOBY MA, Ph.D., CFA

    Financial Analyst

    AE

    ADIL ESSAKHI

    Systems Administrator

    CP

    CATHERINE PROTOPOULOS

    Senior Accountant

    FP

    FREDERIC PFUND

    Marketing Assistant

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    63 investments
    CompanyRoundAmountDate
    Route 92 Medical logoRoute 92 MedicalGrowth$50MApr 2026
    Sling Therapeutics logoSling TherapeuticsSeries C$123MJan 2026
    AAntegrade MedicalSeed$7.3MOct 2025
    SecondWave Systems logoSecondWave SystemsSeries A$7MOct 2025
    IIantrekSeries C$42MAug 2025
    Neuros Medical logoNeuros MedicalSeries D$56MJul 2025
    Neuros logoNeurosSeries D$56MJul 2025
    Shoulder Innovations logoShoulder InnovationsSeries E$40MMar 2025
    Contineum Therapeutics logoContineum TherapeuticsSeries B$30MJan 2025
    IIantrekSeries C—Jan 2025
    Neuros logoNeurosSeries A$56MJan 2025
    AAntegrade MedicalSeed—Jan 2025
    Shoulder Innovations logoShoulder InnovationsSeries E$40MJan 2025
    Evommune logoEvommuneSeries C$115MOct 2024
    Phagenesis logoPhagenesisSeries D—Mar 2024
    Noctrix Health logoNoctrix HealthSeries C$40MJan 2024
    Miach Orthopaedics logoMiach OrthopaedicsBridge—Jan 2023
    Amolyt Pharma logoAmolyt PharmaSeries C$130MJan 2023
    Amolyt Pharma logoAmolyt PharmaSeries C$138MJan 2023
    LENZ Therapeutics logoLENZ TherapeuticsSeries B$83.5MJan 2023
    CurvaFix logoCurvaFixSeries C$39MJan 2023
    Sling Therapeutics logoSling TherapeuticsSeries A$35MJun 2022
    Mineralys Therapeutics logoMineralys TherapeuticsSeries B$118MJun 2022
    MMineralysSeries B$118MJun 2022
    Magnolia Medical Technologies logoMagnolia Medical TechnologiesGrowth$46MFeb 2022
    Page 1 of 3

    Top Co-Investors

    Sofinnova Partners14 shared
    Andera Partners12 shared
    EQT Life Sciences10 shared
    U.S. Venture Partners10 shared
    OrbiMed10 shared
    RA Capital Management8 shared
    Versant Ventures8 shared
    Novo Capital7 shared
    Adams Street Partners6 shared
    Ysios Capital6 shared
    SR One6 shared
    Samsara BioCapital6 shared
    Rock Springs Capital6 shared
    Aperture Venture Partners6 shared
    F-Prime Capital6 shared
    Boulder Ventures5 shared
    HBM Healthcare Investments5 shared
    Catalys Pacific5 shared
    Amzak Health5 shared
    Trinity Capital Inc.5 shared

    Last updated: 20 October 2026